Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrzej Pilc

Showing results (21-30 of 153) with videos related to

Pageof 16
Sort By:
Psychopharmacology|November 21, 2002
Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in miceEwa Kozela, Andrzej Pilc, Piotr Popik
Clinical Drug Investigation|September 8, 2016
Safety Profile of Biologic Drugs in the Treatment of Inflammatory Bowel Diseases: A Systematic Review and Network Meta-analysis of Randomized Controlled TrialsPaweł Moćko, Paweł Kawalec, Andrzej Pilc
European Journal of Clinical Pharmacology|August 8, 2016
Cost-utility analysis of 1-year treatment with adalimumab/standard care and standard care alone for ulcerative colitis in PolandEwa Stawowczyk, Paweł Kawalec, Andrzej Pilc
Expert Opinion on Pharmacotherapy|October 31, 2019
Efficacy and safety of intranasal esketamine for the treatment of major depressive disorderJoanna Kryst, Paweł Kawalec, Andrzej Pilc
Pharmacological Reports : PR|December 31, 2005
Zinc and depression. An updateGabriel Nowak, Bernadeta Szewczyk, Andrzej Pilc
Orphanet Journal of Rare Diseases|September 8, 2016
The correlation between HTA recommendations and reimbursement status of orphan drugs in EuropePaweł Kawalec, Anna Sagan, Andrzej Pilc
Pharmacological Research|July 4, 2012
Simultaneous alterations of brain and plasma serotonin concentrations and liver cytochrome P450 in rats fed on a tryptophan-free dietMarta Kot, Andrzej Pilc, Władysława A Daniel
Behavioural Pharmacology|February 7, 2019
Role of AMPA receptor stimulation and TrkB signaling in the antidepressant-like effect of ketamine co-administered with a group II mGlu receptor antagonist, LY341495, in the forced swim test in ratsAgnieszka Pałucha-Poniewiera, Karolina Podkowa, Andrzej Pilc
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 8, 2009
Group III mGlu receptor agonist, ACPT-I, attenuates morphine-withdrawal symptoms after peripheral administration in miceAgnieszka Pałucha-Poniewiera, Kinga Novák, Andrzej Pilc
Neuropharmacology|March 18, 2014
Activation of the mTOR signaling pathway in the antidepressant-like activity of the mGlu5 antagonist MTEP and the mGlu7 agonist AMN082 in the FST in ratsAgnieszka Pałucha-Poniewiera, Bernadeta Szewczyk, Andrzej Pilc
Pageof 16

Showing results (21-30 of 153) with videos related to

Sort By:
Pageof 16
Psychopharmacology|November 21, 2002
Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in miceEwa Kozela, Andrzej Pilc, Piotr Popik
Clinical Drug Investigation|September 8, 2016
Safety Profile of Biologic Drugs in the Treatment of Inflammatory Bowel Diseases: A Systematic Review and Network Meta-analysis of Randomized Controlled TrialsPaweł Moćko, Paweł Kawalec, Andrzej Pilc
European Journal of Clinical Pharmacology|August 8, 2016
Cost-utility analysis of 1-year treatment with adalimumab/standard care and standard care alone for ulcerative colitis in PolandEwa Stawowczyk, Paweł Kawalec, Andrzej Pilc
Expert Opinion on Pharmacotherapy|October 31, 2019
Efficacy and safety of intranasal esketamine for the treatment of major depressive disorderJoanna Kryst, Paweł Kawalec, Andrzej Pilc
Pharmacological Reports : PR|December 31, 2005
Zinc and depression. An updateGabriel Nowak, Bernadeta Szewczyk, Andrzej Pilc
Orphanet Journal of Rare Diseases|September 8, 2016
The correlation between HTA recommendations and reimbursement status of orphan drugs in EuropePaweł Kawalec, Anna Sagan, Andrzej Pilc
Pharmacological Research|July 4, 2012
Simultaneous alterations of brain and plasma serotonin concentrations and liver cytochrome P450 in rats fed on a tryptophan-free dietMarta Kot, Andrzej Pilc, Władysława A Daniel
Behavioural Pharmacology|February 7, 2019
Role of AMPA receptor stimulation and TrkB signaling in the antidepressant-like effect of ketamine co-administered with a group II mGlu receptor antagonist, LY341495, in the forced swim test in ratsAgnieszka Pałucha-Poniewiera, Karolina Podkowa, Andrzej Pilc
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 8, 2009
Group III mGlu receptor agonist, ACPT-I, attenuates morphine-withdrawal symptoms after peripheral administration in miceAgnieszka Pałucha-Poniewiera, Kinga Novák, Andrzej Pilc
Neuropharmacology|March 18, 2014
Activation of the mTOR signaling pathway in the antidepressant-like activity of the mGlu5 antagonist MTEP and the mGlu7 agonist AMN082 in the FST in ratsAgnieszka Pałucha-Poniewiera, Bernadeta Szewczyk, Andrzej Pilc
Pageof 16